Background: A patient with unresectable periampullary malignancy found at laparotomy has traditionally received a prophylactic double bypass (biliary and duodenal), associated with considerable morbidity. With modern endoscopic treatments, surgical bypass has become questionable. This study aims to compare the two strategies. Sahlgrenska University Hospital (SU) performs a double bypass (DoB) routinely, and Skåne University Hospital Lund (SUL) secures biliary drainage endoscopically and treats only symptomatic duodenal obstruction (Wait and See, WaS).
Method: Between 2004 and 2013, 73 patients from SU and 70 from SUL were retrospectively identified. Demographics, tumour-related factors and postoperative outcomes during the remaining lifetime were noted.
Results: The DoB group had significantly more complications (67% vs. 31%, p = 0.00002) and longer hospital stay (14 vs. 8 days, p = 0.001) than the WaS-group. The two groups had similar proportion of patients in need of readmission. The DoB patients and the WaS patients with metallic biliary stents were comparable regarding their need of re-interventions and hospitalisation due to biliary obstruction. Surgical duodenal bypass did not prevent future duodenal obstructions.
Conclusion: Patients with unresectable periampullary malignancies can safely be managed with endoscopic drainage on demand and with lower morbidity and shorter hospital stay than with surgical prophylactic bypass.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4750237 | PMC |
| http://dx.doi.org/10.1016/j.hpb.2015.08.009 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Surgery for Borderline Resectable Pancreatic Ductal Adenocarcinoma: Preoperative Planning, Technical Considerations, and Building a Program.
Surg Clin North Am
October 2024
Department of Gastrointestinal Oncology, H. Lee Moffitt Cancer Center, Tampa, FL 33612, USA. Electronic address:
Pancreaticoduodenectomy, first described in 1935, has subsequently been refined over decades into the operation performed today for tumors of the pancreatic head and periampullary region. For years following Whipple's first publication, tumors found to be inseparable from the surrounding vasculature were considered locoregionally advanced and unresectable. Fortner began performing regional pancreatectomy with routine enbloc resection of the portal vein/superior mesenteric vein in an attempt to address high local recurrence rates and high rates of aborted operations due to vascular involvement.
View Article and Find Full Text PDFEndoscopic Palliative Treatment for Duodenal and Biliary Obstruction in Advanced Periampullary Malignancy.
Cureus
July 2024
Department of Cardiology, Max Super Speciality Hospital, Delhi, IND.
Unresectable periampullary malignancies can lead to concomitant duodenal and biliary obstructions, significantly affecting patient quality of life. Effective palliation of these obstructions is crucial for symptom management and improving patient outcomes. Endoscopic techniques provide a minimally invasive approach to address these complications.
View Article and Find Full Text PDFLaparoscopic ultrasonography along with staging laparoscopy as a tool for staging in patients with hepatopancreaticobiliary malignancy - A prospective cohort study from a tertiary care centre.
J Minim Access Surg
January 2024
Department of Surgical Disciplines, All India Institute of Medical Sciences, New Delhi, India.
Article Synopsis
- Staging laparoscopy (SL) helps avoid unnecessary surgeries in patients with hepatopancreaticobiliary (HPB) cancers by accurately identifying resectable diseases, but has limitations in detecting deep-seated malignancies.
- In a study from 2017 to 2019, 40 patients underwent SL and laparoscopic ultrasonography, with findings revealing that 20% had undetected metastatic lesions, which impacted their treatment options.
- The study concluded that incorporating laparoscopic ultrasonography improves the detection of deep-seated lesions, aiding in treatment decisions for patients with HPB malignancies.
Neoadjuvant Therapy for Duodenal and Ampullary Adenocarcinoma: A Systematic Review.
Ann Surg Oncol
February 2024
Division of Surgical Oncology, Department of Surgery, University of Nebraska Medical Center, Omaha, NE, USA.
Background: The role of systemic therapy in the management of ampullary (AA) and duodenal adenocarcinoma (DA) remains poorly understood. This study sought to synthesize current evidence supporting the use of neoadjuvant therapy (NAT) in AA and DA.
Methods: The study searched PubMed, Cochrane Library (Wiley), Embase (Elsevier), CINAHL (EBSCO), and ClinicalTrials.
Endoscopic Ultrasound-Guided Biliary Drainage of First Intent With a Lumen-Apposing Metal Stent vs Endoscopic Retrograde Cholangiopancreatography in Malignant Distal Biliary Obstruction: A Multicenter Randomized Controlled Study (ELEMENT Trial).
Gastroenterology
November 2023
Division of Gastroenterology and Hepatology, McGill University Health Centre, Montreal, Quebec, Canada.
Article Synopsis
- EUS-CDS (endoscopic ultrasound-guided choledochoduodenostomy) was compared to ERCP-M (endoscopic retrograde cholangiopancreatography with metal stenting) for treating malignant distal biliary obstruction in a randomized controlled trial involving patients with specific cancer types.
- The study found that EUS-CDS had a shorter procedure time and a high technical success rate (90.4%), comparable to ERCP-M (83.1%), with similar rates of stent dysfunction (9.6% vs 9.9%).
- The results suggest that while EUS-CDS is not superior, it is a safe and efficient alternative to ERCP-M, advocating for its broader use in clinical settings.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!